دورية أكاديمية
Association of hypertension, type 2 diabetes mellitus and dyslipidemia with the duration of inpatient treatments and recurrence of schizophrenia.
| العنوان: | Association of hypertension, type 2 diabetes mellitus and dyslipidemia with the duration of inpatient treatments and recurrence of schizophrenia. |
|---|---|
| المؤلفون: | Lamadé EK; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: eva.lamade@zi-mannheim.de., Özer N; Department of Psychiatry and Psychotherapy, University of Göttingen, Germany., Schaupp B; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Krumm B; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Deuschle M; Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany., Häfner S; Department of Psychiatry and Psychotherapy, University of Göttingen, Germany; Department of Psychiatry and Psychotherapy, University of Heidelberg, Germany. |
| المصدر: | Journal of psychosomatic research [J Psychosom Res] 2023 Sep; Vol. 172, pp. 111436. Date of Electronic Publication: 2023 Jul 04. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Pergamon Press Country of Publication: England NLM ID: 0376333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1360 (Electronic) Linking ISSN: 00223999 NLM ISO Abbreviation: J Psychosom Res Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Oxford : Pergamon Press Original Publication: London. |
| مواضيع طبية MeSH: | Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/therapy , Schizophrenia*/therapy , Schizophrenia*/epidemiology , Hypertension*/epidemiology , Dyslipidemias*/epidemiology , Dyslipidemias*/diagnosis , Diabetes Mellitus*/epidemiology, Humans ; Retrospective Studies ; Inpatients ; Hospitalization ; Risk Factors |
| مستخلص: | Objective: People with schizophrenia have an increased cardiovascular risk with higher mortality than the general population. Only a few studies have investigated the impact of cardiovascular risk on the later course of schizophrenia. This study aims to explore the association of cardiovascular risk factors, as detected during an index inpatient treatment for schizophrenia, with the duration of psychiatric inpatient treatments and number of inpatient admissions in the subsequent 10 years, in patients with schizophrenia. Methods: Cardiovascular risk factors of 736 patients with schizophrenia, identified through retrospective chart review, were assessed by hypertension, type 2 diabetes mellitus and dyslipidemia during an index inpatient stay. The duration of inpatient treatments, assessed by the total duration of psychiatric inpatient treatments in days, and the number of inpatient admissions, over the next 10 years were assessed and analyzed for an association with cardiovascular risk factors. Results: Hypertension associated with longer duration of inpatient treatments and higher number of inpatient admissions. Type 2 diabetes mellitus and dyslipidemia associated with a higher number of psychiatric inpatient treatments. Hypertension remained significantly associated with the duration of inpatient treatments (β = 0.174; p < 0.001) and the number of inpatient treatments (β = 0.144; p < 0.001), when adjusting for age, sex and BMI. Conclusion: Out of the investigated cardiovascular risk factors documented during an index inpatient stay for schizophrenia, only hypertension associated with an increased duration of in-hospital stay and an increased number of re-hospitalizations during the subsequent ten years when adjusting for confounders. Screening for hypertension should be considered in all patients with schizophrenia. Competing Interests: Declaration of Competing Interest The authors have no competing interests to report. (Copyright © 2023 Elsevier Inc. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Cardiovascular risk factors; Diabetes mellitus; Dyslipidemia; Hypertension; Schizophrenia |
| تواريخ الأحداث: | Date Created: 20230716 Date Completed: 20230814 Latest Revision: 20230817 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1016/j.jpsychores.2023.111436 |
| PMID: | 37454415 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1879-1360 |
|---|---|
| DOI: | 10.1016/j.jpsychores.2023.111436 |